Natural History of Quantitative Fatty Infiltration and 3D Muscle Volume After Nonoperative Treatment of Symptomatic Rotator Cuff Tears

Author:

Hochreiter Bettina1ORCID,Germann Christoph2ORCID,Feuerriegel Georg C.2ORCID,Sutter Reto2ORCID,Selman Farah1ORCID,Gressl Maximilian1ORCID,Ek Eugene T.34ORCID,Wieser Karl1ORCID

Affiliation:

1. Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland

2. Department of Radiology, Balgrist University Hospital, University of Zurich, Zurich, Switzerland

3. Melbourne Orthopaedic Group, Melbourne, Victoria, Australia

4. Department of Surgery, Monash Medical Center, Monash University, Melbourne, Victoria, Australia

Abstract

Background: The severity of fatty infiltration (FI) predicts the treatment outcome of rotator cuff tears. The purpose of this investigation was to quantitatively analyze supraspinatus (SSP) muscle FI and volume at the initial presentation and after a 3-month minimum of conservative management. We hypothesized that progression of FI could be predicted with initial tear size, FI, and muscle volume. Methods: Seventy-nine shoulders with rotator cuff tears were prospectively enrolled, and 2 magnetic resonance imaging (MRI) scans with 6-point Dixon sequences were acquired. The fat fraction within the SSP muscle was measured on 3 sagittal slices, and the arithmetic mean was calculated (FISSP). Advanced FISSP was defined as ≥8%, pathological FISSP was defined as ≥13.5%, and relevant progression was defined as a ≥4.5% increase in FISSP. Furthermore, muscle volume, tear location, size, and Goutallier grade were evaluated. Results: Fifty-seven shoulders (72.2%) had normal FISSP, 13 (16.5%) had advanced FISSP, and 9 (11.4%) had pathological FISSP at the initial MRI scan. Eleven shoulders (13.9%) showed a ≥4.5% increase in FISSP at 19.5 ± 14.7 months, and 17 shoulders (21.5%) showed a ≥5-mm3 loss of volume at 17.8 ± 15.3 months. Five tears (7.1%) with initially normal or advanced FISSP turned pathological. These tears, compared with tears that were not pathological, had significantly higher initial mediolateral tear size (24.8 compared with 14.3 mm; p = 0.05), less volume (23.5 compared with 34.2 mm3; p = 0.024), more FISSP (9.6% compared with 5.6%; p = 0.026), and increased progression of FISSP (8.6% compared with 0.5%; p < 0.001). An initial mediolateral tear size of ≥20 mm yielded a relevant FISSP progression rate of 81.8% (odds ratio [OR], 19.0; p < 0.001). Progression rates of 72.7% were found for both initial FISSP of ≥9.9% (OR, 17.5; p < 0.001) and an initial anteroposterior tear size of ≥17 mm (OR, 8.0; p = 0.003). Combining these parameters in a logistic regression analysis led to an area under the receiver operating characteristic curve (AUC) of 0.913. The correlation between FISSP progression and the time between MRI scans was weak positive (ρ = 0.31). Conclusions: Three risk factors for relevant FI progression, quantifiable on the initial MRI, were identified: ≥20-mm mediolateral tear size, ≥9.9% FISSP, and ≥17-mm anteroposterior tear size. These thresholds were associated with a higher risk of tear progression: 19 times higher for ≥20-mm mediolateral tear size, 17.5 times higher for ≥9.9% FISSP, and 8 times higher for ≥17-mm anteroposterior tear size. The presence of all 3 yielded a 91% chance of ≥4.5% progression of FISSP within a mean of 19.5 months. Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Shoulder & Elbow;Bone & Joint 360;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3